Jump to content

Medicare Replacement Drug Demonstration Project


Recommended Posts

Medicare Replacement Drug Demonstration Project

Under a new law, non-small cell lung cancer patients currently taking Iressa (gefitinib) may be eligible to participate in a special Medicare program that could significantly cut the cost of the drug.

The Medicare Replacement Drug Demonstration Project allows up to 50,000 people with Medicare, who have life-threatening diseases (such as lung cancer) to participate and get the benefit of significant savings. Depending on income levels, patients could save between 58 percent and 98 percent from the cost of Iressa.

Who to Call

800-532-5274 -- The Patient Advocate Foundation (PAF)

PAF is helping people enroll in the program. Call to find out if you are eligible. Patients will speak with one of PAF's specialized case managers who will assist them by completing the application for expedited submission.

866-563-5386 --The company that is working directly with the federal government to enroll people.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.